Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2025-12-30 @ 5:08 AM
Study NCT ID:
NCT07195695
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-29
Start Date Type:
ESTIMATED
Primary Completion Date:
2032-02-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-09-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-25
First Submit QC Date:
None
Study First Post Date:
2025-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-19
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED